Red Light Therapy Frequencies: Hz & Pulse Modes

Most red light therapy discussions focus on wavelength — 630nm versus 850nm, red versus near-infrared. But there is a second variable that receives far less attention: frequency, measured in hertz (Hz). This refers to whether the light is delivered as a continuous beam or pulsed on and off at a specific rate.

The question matters because pulsed light and continuous wave (CW) light interact with tissue differently. Some researchers believe pulsing unlocks biological effects that continuous exposure cannot. Others argue the evidence is too thin to justify the added complexity. This article examines what we actually know.

Continuous Wave vs Pulsed Light

Continuous wave (CW) means the LED or laser emits light at a constant intensity for the entire treatment duration. The power output does not fluctuate. This is how the vast majority of consumer red light therapy panels operate.

Pulsed light means the source switches on and off at a defined rate. A device pulsing at 10 Hz turns on and off ten times per second. The pulse can be square-wave (instant on, instant off) or shaped, though most consumer devices use square-wave patterns.

Three parameters define pulsed delivery:

Frequency (Hz) — how many on-off cycles occur per second
Duty cycle (%) — the proportion of each cycle spent in the “on” state. A 50% duty cycle at 10 Hz means the light is on for 50 milliseconds and off for 50 milliseconds in each 100ms cycle
Peak irradiance — the power density during the “on” phase, which is typically higher than the average irradiance

At a 50% duty cycle, the average dose delivered is half that of continuous wave at the same peak irradiance. This is important: if you simply pulse a device without increasing peak power, you deliver less total energy per session.

The Biological Rationale for Pulsing

Cellular Rest Periods

One hypothesis is that mitochondria need brief recovery intervals during photobiomodulation. Cytochrome c oxidase (CCO), the primary chromophore for red and near-infrared light, may become temporarily saturated or enter a refractory state after absorbing photons. Pulsing could allow CCO to “reset” between bursts, potentially improving cumulative photon absorption efficiency (Hashmi et al., 2010, Lasers in Surgery and Medicine; PMID: 21246370).

This theory has some support in cell culture work but has not been conclusively demonstrated in human tissue at the power densities used in consumer devices.

Nitric Oxide Release

Continuous and pulsed light may differ in how they modulate nitric oxide (NO). Photodissociation of NO from CCO is a key mechanism in photobiomodulation. Some researchers have proposed that pulsed delivery creates cyclical NO release patterns that enhance vasodilation compared with steady-state release from CW exposure (Karu, 2008, Photomedicine and Laser Surgery; PMID: 18811514). Again, this remains largely theoretical at the consumer device level.

Resonance With Biological Oscillations

Perhaps the most intriguing rationale is that specific pulse frequencies may resonate with endogenous biological rhythms — brainwave oscillations, cellular calcium signalling cycles, or mitochondrial membrane potential fluctuations. This is where specific Hz values enter the conversation.

10 Hz: Wound Healing and Tissue Repair

The frequency most consistently supported in photobiomodulation research is 10 Hz. Hashmi et al. (2010) conducted a systematic comparison using a mouse wound model and found that 10 Hz pulsed 810nm laser significantly outperformed both CW and other frequencies (100 Hz, 600 Hz) for wound closure rates (PMID: 21246370).

The proposed mechanism involves enhanced fibroblast proliferation and collagen synthesis at this frequency. Ten hertz also falls within the alpha-wave range of neural oscillation, leading some researchers to suggest a resonance effect with cellular signalling pathways.

A study by Brondon et al. (2009) in Lasers in Surgery and Medicine examined human HEP-2 cells exposed to 670nm LED light at CW, 2.5 Hz, 100 Hz, and 600 Hz. They found that pulsed delivery at specific frequencies altered cell proliferation differently compared with CW, though the magnitude of effect was modest (PMID: 19588534).

Clinical relevance: If you are using red light therapy primarily for wound healing, tissue repair, or skin rejuvenation, 10 Hz pulsed mode has the strongest (though still limited) evidence base.

40 Hz: Gamma Entrainment and Neurological Applications

The 40 Hz frequency has gained significant attention following groundbreaking work by Iaccarino et al. (2016) published in Nature. The MIT researchers demonstrated that 40 Hz flickering light (visual gamma entrainment) reduced amyloid-beta plaques and tau phosphorylation in mouse models of Alzheimer’s disease (PMID: 28030002).

Subsequent work by the same group (Martorell et al., 2019, Cell; PMID: 30879788) showed that combining 40 Hz light and sound stimulation produced even greater reductions in amyloid pathology across multiple brain regions in mice, with associated improvements in spatial memory.

How 40 Hz Works

Forty hertz corresponds to the gamma frequency band of neural oscillation. Gamma oscillations are associated with attention, memory consolidation, and information processing. In Alzheimer’s disease, gamma oscillatory activity is disrupted. The theory is that entraining the brain to 40 Hz via flickering light:

Recruits microglia to clear amyloid plaques
Modifies neural circuit activity
Enhances cerebrospinal fluid clearance of waste products
Improves vascular function in the brain

Human Trial Data

The GENUS (Gamma ENtrainment Using Sensory stimulation) clinical trials at MIT have begun testing 40 Hz light flicker in human Alzheimer’s patients. Early results presented at the Alzheimer’s Association International Conference suggest the approach is safe, well-tolerated, and may slow brain atrophy compared with sham treatment (Chan et al., 2021, Alzheimer’s & Dementia).

However, it is crucial to understand that this research uses visual flicker — light perceived through the eyes — not transcranial photobiomodulation applied to the scalp. The mechanism is neural entrainment via the visual pathway, not direct tissue photobiomodulation. Consumer red light therapy panels applied to the body would not replicate this effect.

Some transcranial PBM devices do offer 40 Hz pulsing applied to the scalp, which represents a different (and less well-evidenced) approach. The Vielight Neuro Gamma is one such device specifically designed for 40 Hz transcranial delivery.

Clinical relevance: 40 Hz is relevant primarily for neurological applications delivered via visual flicker or transcranial devices. It does not apply to general body-panel red light therapy.

Other Frequencies in Research

73 Hz

Lapchak et al. (2007) found that 73 Hz pulsed 808nm laser improved outcomes in a rabbit model of embolic stroke, outperforming CW delivery (PMID: 17907005). This frequency was used in the NEST (NeuroThera Effectiveness and Safety Trial) clinical trials for acute ischaemic stroke, though the Phase III trial ultimately failed to meet its primary endpoint.

100 Hz and Above

Higher frequencies (100–1000 Hz) appear in some wound healing and pain research, but the evidence is inconsistent. At very high frequencies, the biological effect may approximate CW because the on-off cycling exceeds the temporal resolution of cellular responses.

292 Hz

Used in some dental photobiomodulation studies for accelerating orthodontic tooth movement. Niche application with limited broader relevance.

The Evidence Is Mixed — Here Is Why

Despite promising individual studies, systematic reviews paint a more cautious picture. A review by Huang et al. (2011) in Dose-Response noted that while pulsed light sometimes outperforms CW in preclinical models, the optimal frequency varies by tissue type, wavelength, and target condition. There is no single “best” frequency for all applications (PMID: 22461763).

Several factors complicate the evidence:

Dose confounding. Many studies comparing pulsed and CW delivery do not adequately control for total energy dose. If a pulsed group receives less total energy due to the duty cycle, any difference in outcomes could reflect dose rather than pulsing per se.

Lack of standardisation. Studies vary enormously in pulse parameters — frequency, duty cycle, peak power, total energy, wavelength, treatment area, and duration. This makes cross-study comparison nearly impossible.

Publication bias. Positive results showing pulsed superiority are more likely to be published than null findings showing no difference from CW.

Animal vs human translation. Most strong evidence for pulsed superiority comes from rodent models. Mouse skin, wound healing, and neural tissue differ substantially from human equivalents.

Duty Cycle: The Overlooked Variable

Even when a frequency is specified, the duty cycle dramatically affects the treatment. Consider 10 Hz at three different duty cycles:

Duty Cycle	On Time	Off Time	Average Power (vs CW)
50%	50 ms	50 ms	50%
30%	30 ms	70 ms	30%
80%	80 ms	20 ms	80%

At 30% duty cycle, you are delivering less than a third of the energy of continuous wave in the same treatment duration. To match CW total dose, you would need to either increase peak power or extend treatment time proportionally.

Most consumer devices that offer pulsing use a 50% duty cycle by default. Some allow adjustment, but few provide guidance on which duty cycle to select for which purpose.

Which Consumer Devices Offer Pulse Mode?

Not all red light therapy panels include pulsing capability. Devices that do include:

Mito Red Light — MitoPRO and MitoADAPT series offer adjustable pulse frequencies (10 Hz, 40 Hz, 73 Hz, 146 Hz, 292 Hz, 584 Hz, and 1168 Hz)
Hooga — Some models include pulse mode at 10 Hz
PlatinumLED BioMAX — Offers pulsing functionality
Kineon Move+ — Uses pulsed laser and LED combination, reportedly at 10 Hz
Vielight — Transcranial devices with 10 Hz (Alpha) and 40 Hz (Gamma) modes, designed specifically for neural applications

Many popular panels from Joovv, Rouge, and BestQool operate exclusively in CW mode. This is not necessarily a disadvantage — continuous wave has the largest overall evidence base in photobiomodulation research.

When to Use Continuous Wave vs Pulsed

Based on the current evidence, here is a practical framework:

Use Continuous Wave When:

You are targeting skin conditions (wrinkles, acne, wound healing) — most dermatological studies used CW
You want simplicity and do not wish to navigate pulse parameter selection
Your primary goal is collagen production, inflammation reduction, or general recovery
You are following a protocol based on published research that used CW delivery

Consider Pulsed Mode (10 Hz) When:

You are targeting wound healing or tissue repair and have a device that supports it
You are interested in optimising cellular response based on the Hashmi et al. findings
You are willing to extend treatment time to compensate for reduced average dose

Consider 40 Hz When:

You are using a transcranial PBM device for cognitive or neurological purposes
You are following a protocol specifically designed for gamma entrainment
Do not use 40 Hz body panels expecting neurological benefits — the mechanism requires visual or transcranial delivery

Stick With CW If Unsure

If you are uncertain, CW is the safer default. It has decades of research behind it across hundreds of clinical trials. The potential advantage of pulsing is marginal in most applications and comes with the risk of under-dosing if duty cycle is not properly accounted for.

Common Misconceptions

“Pulsed light penetrates deeper than CW.” There is no strong evidence for this. Penetration depth is primarily a function of wavelength and tissue optical properties, not pulse frequency. Some studies suggest pulsed delivery may improve energy deposition at depth due to thermal relaxation between pulses, but this applies primarily to high-powered lasers, not LED panels.

“NASA proved that pulsing is better.” NASA-funded research by Whelan et al. used LEDs in both CW and pulsed modes for wound healing in space. While pulsed delivery showed promise, the studies did not demonstrate clear superiority over CW at matched doses (Whelan et al., 2001, Space Medicine and Medical Engineering; PMID: 11776318).

“Higher frequency means faster results.” There is no linear relationship between pulse frequency and treatment efficacy. If anything, the research suggests lower frequencies (10 Hz) may be more effective than higher ones for certain applications, whilst others show no frequency-dependent effect at all.

Practical Recommendations

Do not pay a premium solely for pulse capability unless you have a specific evidence-based reason to use it. CW devices deliver excellent results across the majority of studied applications.
If your device has pulse mode, try 10 Hz at 50% duty cycle for tissue repair applications. Double your treatment time to compensate for reduced average dose compared with CW.
For neurological applications, invest in a purpose-built transcranial device (e.g., Vielight Neuro Gamma at 40 Hz) rather than attempting to repurpose a body panel.
Keep records. If you experiment with pulsed modes, track your parameters (frequency, duty cycle, treatment time) and outcomes. Individual responses vary, and self-tracking is the only way to determine what works for your specific situation.
Watch the research. Pulsed PBM is an active area of investigation. The GENUS trials for Alzheimer’s disease are particularly promising and may reshape how we think about frequency-specific light therapy over the coming years.

Summary

Pulse frequency is a genuine variable in photobiomodulation, but its practical importance for the average user is overstated by marketing. The strongest evidence supports 10 Hz for wound healing (primarily from animal models) and 40 Hz for gamma entrainment in neurological conditions (a distinct mechanism requiring visual or transcranial delivery). For most applications — skin health, pain relief, muscle recovery, joint support — continuous wave delivery remains the best-evidenced approach. If your device offers pulsing, it is worth experimenting with, but it should not be the primary factor driving your purchase decision.

References

Hashmi JT, et al. Effect of pulsing in low-level light therapy. Lasers Surg Med. 2010;42(6):450-466. PMID: 21246370
Iaccarino HF, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540(7632):230-235. PMID: 28030002
Martorell AJ, et al. Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition. Cell. 2019;177(2):256-271. PMID: 30879788
Brondon P, et al. Pulsing influences photoradiation outcomes in cell culture. Lasers Surg Med. 2009;41(3):222-226. PMID: 19588534
Huang YY, et al. Biphasic dose response in low level light therapy — an update. Dose Response. 2011;9(4):602-618. PMID: 22461763
Karu TI. Mitochondrial signaling in mammalian cells activated by red and near-IR radiation. Photochem Photobiol. 2008;84(5):1091-1099. PMID: 18811514
Lapchak PA, et al. Transcranial near-infrared laser transmission (NILT) profiles. Lasers Surg Med. 2007;39(1):36-40. PMID: 17907005
Whelan HT, et al. Effect of NASA light-emitting diode irradiation on wound healing. J Clin Laser Med Surg. 2001;19(6):305-314. PMID: 11776318
Chan D, et al. Gamma frequency sensory stimulation in probable mild Alzheimer’s dementia patients. Alzheimers Dement. 2021;17(S4):e054548